Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer

NCT01080521 is registered in ClinicalTrials.gov with Gynecologic Oncology Group as lead sponsor.

NCT NCT01080521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01080521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of Cognitive Function During Chemotherapy for Front-Line Treatment of Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Lead sponsor
Gynecologic Oncology Group
Phase
Observational
Overall status
Completed
Start date
April 30, 2010
Completion date
January 27, 2018
Enrollment
247 (actual)
Sites
182

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive side effects of cancer therapy, malignant ovarian epithelial tumor, ovarian brenner tumor, ovarian carcinosarcoma, ovarian choriocarcinoma, ovarian clear cell cystadenocarcinoma, ovarian dysgerminoma, ovarian embryonal carcinoma, ovarian endometrioid adenocarcinoma, ovarian mixed germ cell tumor, ovarian mucinous cystadenocarcinoma, ovarian polyembryoma, ovarian sarcoma, ovarian seromucinous carcinoma, ovarian serous cystadenocarcinoma, ovarian teratoma, ovarian yolk sac tumor, stage i ovarian cancer, stage ia fallopian tube cancer, stage ia ovarian cancer, stage ia ovarian germ cell tumor, stage ib fallopian tube cancer, stage ib ovarian cancer, stage ib ovarian germ cell tumor, stage ic fallopian tube cancer, stage ic ovarian cancer, stage ic ovarian germ cell tumor, stage ii ovarian cancer, stage iia fallopian tube cancer, stage iia ovarian cancer, stage iia ovarian germ cell tumor, stage iib fallopian tube cancer, stage iib ovarian cancer, stage iib ovarian germ cell tumor, stage iic fallopian tube cancer, stage iic ovarian cancer, stage iic ovarian germ cell tumor, stage iiia fallopian tube cancer, stage iiia ovarian cancer, stage iiia ovarian germ cell tumor, stage iiia primary peritoneal cancer, stage iiib fallopian tube cancer, stage iiib ovarian cancer, stage iiib ovarian germ cell tumor, stage iiib primary peritoneal cancer, stage iiic fallopian tube cancer, stage iiic ovarian cancer, stage iiic ovarian germ cell tumor, stage iiic primary peritoneal cancer, stage iv fallopian tube cancer, stage iv ovarian cancer, stage iv ovarian germ cell tumor, stage iv primary peritoneal cancer, undifferentiated ovarian carcinoma